Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 2Dermatologic 2

Conditions

Keratosis, Actinic 34Carcinoma, Basal Cell 9Skin Neoplasms 5Precancerous Conditions 4Squamous Intraepithelial Lesions 2Skin Diseases 2Lymphoma, T-Cell, Cutaneous 2Carcinoma, Squamous Cell 2Basal Cell Nevus Syndrome 2Sezary Syndrome 1Nonmelanoma Skin Cancers 1Non-Melanoma Skin Cancer (NMSC) 1Neoplasms, Basal Cell 1Mycosis Fungoides 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

binimetinib 2Aminolevulinic Acid 2methyl 5-aminolevulinate 1encorafenib 1Vemurafenib 1Radiotherapy 1Radiation 1Photochemotherapy 1Fluorouracil 1Floderm topical cream 1Equipment and Supplies 1Dacarbazine 1BF-200 ALA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Skin Diseases × Aminolevulinic Acid × Dermatologic × Clear all
NCT07144345 2026-04-22

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

Sun Pharmaceutical Industries Limited

Phase 3 Recruiting
160 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT07144852 2026-04-22

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

Sun Pharmaceutical Industries Limited

Phase 3 Recruiting
260 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡